Emcure Pharmaceuticals Limited has informed the Exchange about Link of Recording
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Emcure Pharmaceuticals has shared with the stock exchanges that the audio recording of its Q4 FY25 earnings call, held on May 22, 2025, is now available on its website. The disclosure is being made under SEBI's listing regulations, following an earlier intimation dated May 13, 2025 about the earnings call. The recording can be accessed via a direct link hosted on the Emcure website. The filing itself does not contain any financial figures or management commentary — it is purely an administrative compliance update.
This is a routine compliance disclosure with no direct impact on the stock price. Investors who want to hear management's detailed Q4 FY25 commentary and any forward-looking statements should listen to the audio recording on the company's website.